Stockholders' Equity (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
|---|
| Stockholders' Equity Note [Abstract] |
|
| Schedule of Number of Common Stock Reserved for Future Issuance |
As of March 31, 2026, and December 31, 2025, the Company had reserved common stock for future issuance as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2026 |
|
|
2025 |
|
Conversion of outstanding warrants |
|
|
102,299 |
|
|
|
102,299 |
|
Outstanding options |
|
|
3,935,100 |
|
|
|
4,135,501 |
|
Outstanding RSUs |
|
|
1,648,022 |
|
|
|
1,561,534 |
|
Shares reserved for future issuance under the Company's equity plans |
|
|
7,267,978 |
|
|
|
5,279,680 |
|
Total |
|
|
12,953,399 |
|
|
|
11,079,014 |
|
|
| Schedule of Option Activity Under The Plans |
Activity under the 2014 Stock Incentive Plan (the “2014 Plan”), 2024 Equity Incentive Plan (the “2024 EIP”), and 2024 Incentive Award Plan (the “2024 Plan”) is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
average |
|
|
Aggregate |
|
|
|
Number of |
|
|
Weighted
average |
|
|
remaining
contractual |
|
|
intrinsic
value |
|
|
|
options |
|
|
exercise price |
|
|
life (in years) |
|
|
(in thousands) |
|
Balance at December 31, 2025 |
|
|
4,135,501 |
|
|
$ |
8.70 |
|
|
|
7.38 |
|
|
|
54,842 |
|
Options granted |
|
|
83,025 |
|
|
|
22.02 |
|
|
|
|
|
|
|
Options exercised |
|
|
(232,777 |
) |
|
|
4.66 |
|
|
|
|
|
|
|
Options forfeited |
|
|
(50,649 |
) |
|
|
10.18 |
|
|
|
|
|
|
|
Balance at March 31, 2026 |
|
|
3,935,100 |
|
|
|
9.24 |
|
|
|
7.29 |
|
|
|
36,509 |
|
Options vested and expected to vest as of March 31, 2026 |
|
|
3,935,100 |
|
|
|
9.24 |
|
|
|
7.29 |
|
|
|
36,509 |
|
Options exercisable at March 31, 2026 |
|
|
2,460,544 |
|
|
$ |
6.74 |
|
|
|
6.67 |
|
|
|
28,651 |
|
|
| Schedule of Restricted Stock Activity |
Restricted Stock Unit activity under the plans is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of |
|
|
Weighted average |
|
|
|
shares |
|
|
grant date fair value |
|
Unvested at December 31, 2025 |
|
|
1,561,534 |
|
|
$ |
17.94 |
|
Granted |
|
|
241,448 |
|
|
|
21.42 |
|
Vested |
|
|
(96,073 |
) |
|
|
19.98 |
|
Cancelled |
|
|
(58,887 |
) |
|
|
17.67 |
|
Unvested at March 31, 2026 |
|
|
1,648,022 |
|
|
$ |
18.31 |
|
|
| Schedule of Assumptions Used for Estimate of Fair Value of Options |
The fair value of employee stock options granted was estimated using the following weighted-average assumptions for the three months ended March 31, 2026 and 2025:
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, |
|
|
2026 |
|
2025 |
Expected term (in years) |
|
|
4.9 |
|
|
|
|
5.5 |
|
|
Expected volatility |
|
|
71.0 |
% |
|
|
|
63.4 |
% |
|
Risk-free interest rate |
|
|
3.8 |
% |
|
|
|
4.5 |
% |
|
Dividend yield |
|
— |
|
|
|
— |
|
|
|
| Schedule of Total Stock Based Compensation Expense |
The Company’s total stock-based compensation expense was as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, |
|
|
2026 |
|
2025 |
Cost of revenue |
|
$ |
148 |
|
|
|
$ |
25 |
|
|
Research and development |
|
|
700 |
|
|
|
|
373 |
|
|
Sales and marketing |
|
|
1,510 |
|
|
|
|
777 |
|
|
General and administrative |
|
|
1,365 |
|
|
|
|
1,173 |
|
|
Total stock-based compensation expense |
|
$ |
3,723 |
|
|
|
$ |
2,348 |
|
|
|